2018
DOI: 10.1016/j.fjps.2018.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Design and in vivo pharmacokinetic study of a newly developed lamivudine transdermal patch

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 53 publications
0
7
0
Order By: Relevance
“…Such formulae were applied to the mice's dorsum and covered by Tegaderm (3M Health Care, USA) and additionally secured firmly by specially designed mouseVelcro jackets. 23,24 In the present study, pure CEO was topically applied for comparison. It was reported that the anti-inflammatory activity of NE containing eugenol, the main component of CEO, against carrageenan-induced paw edema model was proved with no significant difference in the concentration range of 1-4% (w/w).…”
Section: In Vivo Anti-inflammatory Activity Against Croton Oil-inducementioning
confidence: 99%
“…Such formulae were applied to the mice's dorsum and covered by Tegaderm (3M Health Care, USA) and additionally secured firmly by specially designed mouseVelcro jackets. 23,24 In the present study, pure CEO was topically applied for comparison. It was reported that the anti-inflammatory activity of NE containing eugenol, the main component of CEO, against carrageenan-induced paw edema model was proved with no significant difference in the concentration range of 1-4% (w/w).…”
Section: In Vivo Anti-inflammatory Activity Against Croton Oil-inducementioning
confidence: 99%
“…3 (A-C). The resultant dried films were then cut into smaller films such that the weight of these films was maintained [ 16 ].
Fig.
…”
Section: Methodsmentioning
confidence: 99%
“…Biodegradable blends of sodium alginate (SA) and lignosulphonic acid (LS) in a ratio of 80:20 is known to work best in the case of controlled drug delivery [ 12 , 13 ]. Polyethylene glycol (PEG) and glycerol are non-toxic, biodegradable, and known to be efficient plasticizers [ [13] , [14] , [15] , [16] ]. PEGylation, the covalent conjugation of PEG with various drug targets, such as protein and oligonucleotides, improves the drug's pharmacokinetics [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…There are HA-based scaffolds that can be used in wound healing as potential bioactive dressings such as bandages, topical gels, microspheres, nanoparticles, hydrocolloids, foams, transdermal/matrix patches, etc. [ 94 ]. Hussain et al reported HA-functionalized nanoparticles for the co-delivery of resveratrol and curcumin for chronic diabetic wound treatment [ 95 ].…”
Section: Bioactive Agents Loaded Hyaluronic Acid Scaffoldsmentioning
confidence: 99%